A new tetravalent Dengue vaccine formulation based on four chimeric envelope domain III-capsid proteins induces a functional immune response in mice and non-human primates
Main Authors: | Edith Suzarte, Lázaro Gil, Lisset Hermida, Ernesto Marcos, Iris Valdés, Laura Lazo, Gerardo Guillén, Mayling Álvarez, Alienys Izquierdo, María G Guzmán, Yusleidi Pérez, Angélica García, José A Silva, Jorge Castro, Enma Brown, Alexander Hernández, Yadira Rodríguez, Lázaro López, Yassel Ramos, Viviana Falcón, Rosa Ramírez, Yaremis Romero, Aracelys Blanco, Oney Ortega, Aina Mendez, Karem Cobas, Sonia González, Mariela Vazquez |
---|---|
Format: | Article |
Language: | English |
Published: |
Elfos Scientiae
|
Series: | Biotecnología Aplicada |
Subjects: | |
Online Access: | http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1027-28522016000200007&lng=en&tlng=en |
Similar Items
-
The Relevance of Tetravalent Influenza Vaccines. World experience
by: A. D. M. E. Osterhaus
Published: (2018-09-01) -
Tetravalent neoglycoсonjugate based on the d-galactose for medicine purposes
by: A. I. Magasumova, et al.
Published: (2015-08-01) -
Efficacy of tetravalent dengue vaccine: A systematic review and meta-analysis
by: Ashish Wasudeo Khobragade, et al.
Published: (2021-01-01) -
Use of Tetravalent Galabiose for Inhibition of Streptococcus Suis Serotype 2 Infection in a Mouse Model
by: Karen A. Krogfelt, et al.
Published: (2013-04-01) -
Tetravalent dengue DNA vaccine is not immunogenic when delivered by retrograde infusion into salivary glands
by: Guy El Helou, et al.
Published: (2020-06-01)